1. Home
  2. WORX vs DCOY Comparison

WORX vs DCOY Comparison

Compare WORX & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

HOLD

Current Price

$0.12

Market Cap

4.3M

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$0.59

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WORX
DCOY
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.7M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
WORX
DCOY
Price
$0.12
$0.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
15.7M
145.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
79.79
N/A
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.57
52 Week High
$1.37
$1.41

Technical Indicators

Market Signals
Indicator
WORX
DCOY
Relative Strength Index (RSI) 32.74 39.60
Support Level N/A N/A
Resistance Level $0.35 $0.83
Average True Range (ATR) 0.07 0.06
MACD -0.03 -0.01
Stochastic Oscillator 2.78 23.64

Price Performance

Historical Comparison
WORX
DCOY

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Share on Social Networks: